ENVESTNET ASSET MANAGEMENT INC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$345,669
-50.0%
41,348
+48.6%
0.00%
Q2 2023$691,098
+189.9%
27,822
+75.5%
0.00%
Q1 2023$238,369
+92.7%
15,849
+51.6%
0.00%
Q4 2022$123,683
-56.6%
10,455
+21.9%
0.00%
Q3 2021$285,000
-40.9%
8,574
-31.0%
0.00%
Q2 2021$482,000
-8.4%
12,421
+13.9%
0.00%
Q1 2021$526,000
+49.9%
10,908
+61.5%
0.00%
Q4 2020$351,0006,7540.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders